药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Ranibizumab
Technetium Tc-99m mebrofenin
The excretion of Technetium Tc-99m mebrofenin can be decreased when combined with Pitavastatin.
Ranibizumab
Gadoxetic acid
The excretion of Gadoxetic acid can be decreased when combined with Pitavastatin.
Ranibizumab
Cholecystokinin
The excretion of Cholecystokinin can be decreased when combined with Pitavastatin.
Ranibizumab
Atrasentan
The excretion of Atrasentan can be decreased when combined with Pitavastatin.
Ranibizumab
Daclatasvir
The serum concentration of Pitavastatin can be increased when it is combined with Daclatasvir.
Ranibizumab
Ripretinib
Ripretinib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Glecaprevir
Glecaprevir may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Pibrentasvir
Pibrentasvir may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Rucaparib
Rucaparib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Voxilaprevir
Voxilaprevir may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Abemaciclib
Abemaciclib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Velpatasvir
Velpatasvir may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Venetoclax
Venetoclax may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Alectinib
Alectinib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Paritaprevir
Paritaprevir may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Rolapitant
Rolapitant may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Cobicistat
Cobicistat may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Afatinib
Afatinib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Regorafenib
Regorafenib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Ranibizumab
Rilpivirine
Rilpivirine may decrease the excretion rate of Pitavastatin which could result in a higher serum level.